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Background: Intra-amniotic infection accounts for 30% of all preterm births (PTB), with the human 
Ureaplasma species being the most frequently identified microorganism from the placentas of 
women who deliver preterm. The highest prevalence of PTB occurs late preterm (32-36 weeks) but 
no studies have investigated the role of infectious aetiologies associated with late preterm birth.  
 
Method: Placentas from women with late PTB were dissected aseptically and samples of 
chorioamnion tissue and membrane swabs were collected. These were tested for Ureaplasma spp. 
and aerobic/anaerobic bacteria by culture and real-time PCR. Western blot was used to assess MBA 
variation in ureaplasma clinical isolates. The presence of microorganisms was correlated with 
histological chorioamnionitis.  
 
Results: Ureaplasma spp. were isolated from 33/466 (7%) of placentas by culture or PCR. The 
presence of ureaplasmas, but not other microorganisms, was associated with histological 
chorioamnionitis (21/33 ureaplasma-positive vs. 8/42 other bacteria; p= 0.001). Ureaplasma clinical 
isolates demonstrating no MBA variation were associated with histological chorioamnionitis. By 
contrast, ureaplasmas displaying MBA variation were isolated from placentas with no significant 
histological chorioamnionitis (p= 0.001).  
Conclusion:  Ureaplasma spp. within placentas delivered late preterm (7%) is associated with 
histological chorioamnionitis (p = 0.001). Decreased inflammation within chorioamnion was 
observed when the clinical ureaplasma isolates demonstrated variation of their surface-exposed 
lipoproteins (MBA). This variation may be a mechanism by which ureaplasmas modulate and evade 
the host immune response. So whilst ureaplasmas are present intra-amniotically they are not 
suspected because of the normal macroscopic appearance of the placentas and the amniotic fluid. 
 
 
